Physician profile
Stacy Quinn
NPI 1275894529
$1,987.76
in general payments reported to CMS, 2019-2025
24 companies · $23.93 in 2025
The $23.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $671 · 2021: $323 · 2022: $169 · 2023: $13.65 · 2025: $23.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $499.73 | 2019-2022 | |
| Lilly USA, LLC | $307.53 | 2019-2021 | |
| Amgen INC. | $225.12 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $213.66 | 2019-2021 | |
| Allergan, INC. | $148.61 | 2019-2020 | |
| Amarin Pharma, INC. | $65.13 | 2020-2021 | |
| Vivus LLC | $64.45 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.19 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.32 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.59 | 2019-2020 | |
| Abbvie INC. | $45.58 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $30.78 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $28.49 | 2021 | |
| Daiichi Sankyo INC. | $24.79 | 2019 | |
| Boston Scientific Corporation | $23.93 | 2025 | Watchman Flx |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.92 | 2020 | |
| Merck Sharp & Dohme LLC | $19.00 | 2021 | |
| Pfizer INC. | $16.93 | 2021 | |
| Endo Pharmaceuticals INC. | $15.74 | 2020 | |
| Medline Industries LP | $13.65 | 2023 | |
| Horizon Therapeutics Plc | $11.24 | 2020 | |
| Sanofi Pasteur INC. | $11.12 | 2020 | |
| Glaxosmithkline, LLC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.